BioTech Firm Says Heller Ehrman Patent Gaffe Cost It $100M
A biotechnology firm that allegedly lost $100 million after Heller Ehrman LLP failed to notify it of a lapsed patent application asked a California bankruptcy judge on Friday to allow its...To view the full article, register now.
Already a subscriber? Click here to view full article